Neonatal Sepsis

PURPOSE OF REVIEW: Neonatal sepsis is a diagnosis made in infants less than 28 days of life and consists of a clinical syndrome that may include systemic signs of infection, circulatory shock, and multisystem organ failure. RECENT FINDINGS: Commonly involved bacteria include Staphylococcus aureus an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ershad, Muhammed, Mostafa, Ahmed, Dela Cruz, Maricel, Vearrier, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Infectious Disease (J Glauser, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100521/
https://www.ncbi.nlm.nih.gov/pubmed/32226657
http://dx.doi.org/10.1007/s40138-019-00188-z
_version_ 1783511451887992832
author Ershad, Muhammed
Mostafa, Ahmed
Dela Cruz, Maricel
Vearrier, David
author_facet Ershad, Muhammed
Mostafa, Ahmed
Dela Cruz, Maricel
Vearrier, David
author_sort Ershad, Muhammed
collection PubMed
description PURPOSE OF REVIEW: Neonatal sepsis is a diagnosis made in infants less than 28 days of life and consists of a clinical syndrome that may include systemic signs of infection, circulatory shock, and multisystem organ failure. RECENT FINDINGS: Commonly involved bacteria include Staphylococcus aureus and Escherichia coli. Risk factors include central venous catheter use and prolonged hospitalization. Neonates are at significant risk of delayed recognition of sepsis until more ominous clinical findings and vital sign abnormalities develop. Blood culture remains the gold standard for diagnosis. SUMMARY: Neonatal sepsis remains an important diagnosis requiring a high index of suspicion. Immediate treatment with antibiotics is imperative.
format Online
Article
Text
id pubmed-7100521
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-71005212020-03-27 Neonatal Sepsis Ershad, Muhammed Mostafa, Ahmed Dela Cruz, Maricel Vearrier, David Curr Emerg Hosp Med Rep Infectious Disease (J Glauser, Section Editor) PURPOSE OF REVIEW: Neonatal sepsis is a diagnosis made in infants less than 28 days of life and consists of a clinical syndrome that may include systemic signs of infection, circulatory shock, and multisystem organ failure. RECENT FINDINGS: Commonly involved bacteria include Staphylococcus aureus and Escherichia coli. Risk factors include central venous catheter use and prolonged hospitalization. Neonates are at significant risk of delayed recognition of sepsis until more ominous clinical findings and vital sign abnormalities develop. Blood culture remains the gold standard for diagnosis. SUMMARY: Neonatal sepsis remains an important diagnosis requiring a high index of suspicion. Immediate treatment with antibiotics is imperative. Springer US 2019-06-19 2019 /pmc/articles/PMC7100521/ /pubmed/32226657 http://dx.doi.org/10.1007/s40138-019-00188-z Text en © Springer Science+Business Media, LLC, part of Springer Nature 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Infectious Disease (J Glauser, Section Editor)
Ershad, Muhammed
Mostafa, Ahmed
Dela Cruz, Maricel
Vearrier, David
Neonatal Sepsis
title Neonatal Sepsis
title_full Neonatal Sepsis
title_fullStr Neonatal Sepsis
title_full_unstemmed Neonatal Sepsis
title_short Neonatal Sepsis
title_sort neonatal sepsis
topic Infectious Disease (J Glauser, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100521/
https://www.ncbi.nlm.nih.gov/pubmed/32226657
http://dx.doi.org/10.1007/s40138-019-00188-z
work_keys_str_mv AT ershadmuhammed neonatalsepsis
AT mostafaahmed neonatalsepsis
AT delacruzmaricel neonatalsepsis
AT vearrierdavid neonatalsepsis

Ejemplares similares